This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BioElectronics Announces RecoveryRx™ Product Distribution In Ireland

FREDERICK, Md., March 21, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, technological solutions for chronic and post-operative wound care, announced today that it has begun distribution in Ireland of its RecoveryRx™ product line with O'Neill Healthcare ( www.onhealthcare.ie).  RecoveryRx™ ( www.recoveryrx.co) medical devices provide labor free, 24-hour therapy to reduce pain, inflammation, and to accelerate healing.

O'Neill Healthcare is one of the leading providers of medical products in Ireland catering to people with special needs and reduced mobility.  Their sales are focused on Occupational Therapists, Physiotherapists, Public Health Nurses, Hospitals, and Nursing Homes.

"We are pleased to add O'Neill Healthcare, an experienced and successful distributor, to our rapidly expanding hospital, clinic, and medical offices network of twenty-four (24) RecoveryRx™ distributors," said Erin Sanders, Sales Manager, BioElectronics.

About BioElectronics Corporation

BioElectronics Corporation is an award winning medical device developer and manufacturer of advanced medical devices.  Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx™ for chronic and post-operative wound care.   For more information, please visit www.bielcorp.com.

Contact:

Paul Knopick940.262.3584 pknopick@eandecommunications.com   

SOURCE BioElectronics Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs